Dr. Sang Ho Ma, Ph.D. in Pharmacy, is Vice President of Development at A&J Science and a member of the Expert Committee of the Ministry of Food and Drug Safety (MFDS). With over 20 years of
experience in drug discovery and development, including CMC, regulatory affairs, and clinical research, he provides expertise across immuno-oncology, rare diseases, infectious diseases, and vaccines.
Jaeyoung Hyun serves as Head of the Business Development Unit at GCCL(Global Clinical Central Lab), a leading central lab in Asia Pacific specializing in clinical trial sample analysis for global pharmaceutical and biotech sponsors. In this role, he oversees domestic and global client engagement, strategic sales, and partnership development, driving GCCL’s growth and international presence.
With a long-standing career in domestic sales and business development within the pharmaceutical and healthcare industries, Mr. Hyun has cultivated deep expertise in fostering client relationships, shaping commercial strategies, and supporting multinational clinical programs. His professional background includes extensive collaboration with pharma and biotech companies, with a focus on overcoming logistical barriers in clinical sample management—an area he will address in his OCT Korea 2025 session, “Optimizing Central Lab Supply Chains: Overcoming Logistical Barriers in Clinical Sample Management.”
Amy is a seasoned imaging clinical trial expert with a PhD in Biomedical Sciences and extensive experience in the design, execution, and evaluation of imaging across multiple therapeutic areas, including oncology, ophthalmology, neurology, dermatology, musculoskeletal, and gastroenterology. With nearly a decade of leadership in managing imaging projects, she has worked with global pharmaceutical companies, leading CROs, and major hospitals worldwide. Her career journey spans roles from imaging project manager to CEO of a Singapore-based imaging CRO, and she now brings her expertise to a global imaging CRO.
Ms. Eun-Ah Paek, Executive Director at Boryung Co., Ltd., majored in Pharmacy at Sookmyung Women’s University, where she also earned her Master’s degree in Pharmacology. She subsequently completed her doctoral coursework in Pharmacoepidemiology at Sungkyunkwan University.
She previously served as a project leader for central nervous system (CNS) drug development at SK Biopharm and is currently in charge of clinical trials, post-marketing clinical research, pharmacovigilance, and medical writing as the head of the Clinical Division at Boryung.
With over 30 years of experience, she has been involved in comprehensive drug development, spanning from non-clinical research to clinical trials and post-marketing activities for pharmaceuticals.
Education: Department of Business, Tourism and Accounting, Major in Business Administration, Kangwon National University
Career: Daewon Pharmaceutical Co Ltd (Medical Representative – Distribution Manager – Sales Planner – Big Data Specialist)
Experienced clinical development leader with a proven record in strategic decision-making and cross-functional team leadership within global pharmaceutical organizations.
Expertise spans immunology, oncology, and allergy therapeutic areas, with deep experience in cross-border regulatory engagement and clinical trial execution.
Combines scientific rigor with a business-focused mindset, currently pursuing a PhD in health economics to further strengthen academic and strategic capabilities.
Benjamin Sanders is Senior Vice President of Strategy and Emerging Products at Lantern Specialty Care, where he leads corporate strategy, analytics, and the development of new service lines. Previously, Ben was at McKinsey & Company, advising Fortune 100 companies on large-scale transformations, digital strategy, and operational turnarounds. He began his career in political strategy, shaping messaging for national and international campaigns. Ben holds an MBA in Finance from Northwestern University’s Kellogg School of Management and a B.S. in Social Policy from Northwestern.